MoneyWorks4Me

Clarification sought from Aurobindo Pharma

01 Feb 2016 Evaluate

The Exchange has sought clarification from Aurobindo Pharma today with reference to news displayed - in MONEYCONTROL on February 01, 2016 : ‘unit 3 and unit 7 inspected USFDA,UNIT 7 sees few observations’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..